Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex

Journal of Clinical Microbiology

Volumn 36, Issue 9, 1998, Pages 2471-2476

  Magdalena, Juana ^a   Supply, Philip ^a   Locht, Camille ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MYCOLIC ACID;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; IMMUNOTHERAPY; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; TUBERCULOSIS; VIRULENCE;

ACTINOBACTERIA (CLASS); MYCOBACTERIUM; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0031874476     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.9.2471-2476.1998     Document Type: Article

References (26)

1. Abou-Zeid, C., I. Smith, J. Grange, J. Steele, and G. Rook 1986. Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J. Gen. Microbiol. 132:3047-3053.
2. Brosman, S. A. 1992. Bacillus Calmetle-Guérin immunotherapy. Urol. Clin. N. Am. 19:557-564.
3. Calmette, A., G. Guérin, L. Nègre, and A. Boquet. 1926. Prémunition des nouveaux-nés contre la tuberculose par le vaccin BCG, 1921-1926. Ann. Inst. Pasteur (Paris) 40:89-133.
4. Edwards, K. M., and D. S. Kernolde. 1996. Possible hazards of routine bacillus Calmette-Guérin immunization in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 15:836-838.
5. Floyd, M. M., V. A. Silcox, W. D. Jones, Jr., W. R. Butler, and J. O. Kilburn. 1992. Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by high-performance liquid chromatography of mycolic acids. J. Clin. Microbiol. 30:1327-1330.
6. Fomukong, N. G, J. W. Dale, T. W. Osborn, and J. M. Grange. 1992. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J. Appl. Bacteriol. 72:126-133.
7. Frothingham, R. 1995. Differentiation of strains in Mycobacterium tuberculosis complex by DNA sequence polymorphisms, including rapid identification of M. bovis BCG. J. Clin. Microbiol 33:840-844.
8. Frothingham, R., and K. H. Wilson. 1994. Molecular phylogeny of the Mycobacterium avium complex demonstrates clinically meaningful divisions. J. Infect. Dis. 169:305-312.
9. Harboe, M., and S. Nagai. 1984. MPB70 a unique antigen of Mycobacterium bovis BCG. Am. Rev. Respir. Dis. 129:444-452.
10. Hermans, P. W. M., D. van Soolingen, and J. D. A. van Embden. 1992. Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae. J. Bacteriol. 174:4157-4165.
11. Huh, Y. J., D. I. Ahn, and S. J. Kim. 1995 Limited variation of DNA fingerprints (IS6110 and IS1081) in Korean strains of Mycobacterium tuberculosis. Tubercle Lung Dis. 76:324-329.
12. Jones, W. D., Jr. 1975. Differentiation of known strains of BCG from isolates of Mycobacterium bovis and Mycobacterium tuberculosis by using mycobacteriophage 33D. J. Clin. Microbiol. 1:391-392.
13. Kristjansson, M., P. Green, H. L. Manning, A. M. Slutsky, S. M. Brecher, C. F. von Reyn, R. D. Arbeit, and J. N. Maslow. 1993. Molecular confirmation of bacillus Calmelte-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin. Infect. Dis. 17:228-230.
14. Lagranderie, M. R. R., A.-M. Balazuc, E. Deriaud, C. D. Leclerc, and M. Gheorghiu. 1996. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect. Immun. 64:1-9.
15. Lamm, D. L. 1992. Complications of bacillus Calmette-Guérin immunotherapy. Urol. Clin. N. Am. 19:565-572.
16. Lotte, A., O. Wasz-Hockert, and N. Poisson. 1988. Second IUATLD study on complications included by intradermal BCG-vaccination. Bull. Int. Union Tuberc. 63:47-59.
17. Lotte, A., O. Wasz-Hockert, N. Poisson, N. Dumitrescu, M. Verron, and E. Couvet. 1984. BCG complications: estimates for the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res. 21:107-193.
18. Lugosi, L. 1992. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review. Tubercle Lung Dis. 73:252-261.
19. Magdalena, J., A. Vachée, P. Supply, and C. Locht. 1998. Identification of new DNA region specific for members of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 36:937-943.
20. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
21. Minnikin, D. E., S. M. Minnikin, G. Dobson, M. Goodfellow, F. Portaels, L. van den Breen, and D. Sesardic. 1983. Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J. Gen. Microbiol. 129:889-891.
22. Raviglione, M. C., D. E. J. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis-morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
23. Sauton, B. 1912. Sur la nutrition minérale du bacille tuberculeux. C. R. Acad. Sci. 155:860.
24. Supply, P., J. Magdalena, S. Himpens, and C. Locht. 1997. Identification of novel intergenic repetitive units in a mycobacterial two-component system operon. Mol. Microbiol. 26:991-1003.
25. Talbot, E. A., D. L. Williams, and R. Frothingham. 1997. PCR identification of Mycobacterium bovis BCG. J. Clin. Microbiol. 35:566-569.
26. van Soolingen, D., P. W. M. Hermans, P. E. W. de Haas, and J. D. A. van Embden. 1992. Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J. Clin. Microbiol. 30: 1772-1777.